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Background: Tuberculosis remains the foremost cause of morbidity and mortality, more than any other single
infectious disease in the world. Cell mediated immune response plays a crucial role in the control of tuberculosis.
Therefore, measuring cell mediated immune response against the antigens is having a vital role in understanding
the pathogenesis of tuberculosis, which will also help in the diagnosis of and vaccination for tuberculosis.
Findings: The aim of the present study was to compare and optimize the assay conditions to measure the cell
mediated immune response against M. tuberculosis specific antigens. Because the conventional PBMC assays
(due to requirement of large volume of blood sample) are unable to screen more number of antigens within the
same blood sample. So, here we have compared 6 days culture supernatants of 1:5 and 1:10 diluted blood and
PBMCs from healthy laboratory volunteers, to assess the proliferative response of T lymphocytes and secreted IFN-γ
levels against purified recombinant antigen of M. tuberculosis (MPT51, Rv3803c), crude antigens of M. tuberculosis
(PPD) and mitogen (PHA).
Conclusions: We have observed good correlation between each assay and also the mean difference of these
assays did not reach the statistical significance (p > 0.05). From these results, we conclude that 1:10 diluted
whole-blood cultures can be well-suited as an alternative assay to measure cytokine production and lymphocyte
proliferation in comparison to the conventional PBMC assays. Moreover, 1:10 diluted blood assays require less
volume of blood when compared to PBMC assays which will be useful particularly in paediatric and field studies in
endemic countries, where blood volume is a limiting factor.
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Background
Human tuberculosis (TB) is a contagious infection caused
by an intracellular pathogen, Mycobacterium tuberculosis.
Due to lack of accurate diagnostic techniques and vaccines,
TB has become the second leading cause of death from an
infectious disease worldwide and it was declared as ‘global
emergency’ by WHO in 1993. This deadly infection leads
to 8.5–9.2 million new TB cases with 1.1 million deaths
annually; more over 2 billion people are latently infected
with M. tuberculosis [1]. This situation is further compli-
cated by the emergence of multidrug-resistant strains of
bacteria and HIV co-infection.
Cell mediated immune response includes different T
cells (i.e. CD4+, CD8+ and γ/δ T cells) and T cell derived* Correspondence: alameluraja@gmail.com
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distribution, and reproduction in any mediumcytokines play a pivotal role in the protection against M.
tuberculosis [2,3]. Among the existing cytokines, IFN-γ is a
key cytokine in the control of M. tuberculosis infection, and
was confirmed by using IFN-γ knockout mice, which were
more susceptible to virulent M. tuberculosis [4]. Individuals
defective in genes for IFN-γ or the IFN-γ receptor are
prone to serious mycobacterial infections including
M. tuberculosis [5]. IFN-γ is predominantly secreted by
T cells, as well as Natural Killer (NK) cells which play an
important role in macrophage activation which in turn
will contain and kill intracellular mycobacteria [6], control
mycobacteria replication and granuloma formation both
in humans and mice [7].
The ability of T cells to proliferate in response to antigen
has been used as an indicator for the presence of antigen-
specific T cells. Thus, measuring T cell functions in terms
of lymphocyte proliferation and quantification of IFN-γ,
in vitro, against M. tuberculosis specific antigens are usefulCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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trials and the diagnosis of tuberculosis [8].
Two different assay methods exist to analyze the
T-lymphocyte functions, namely Peripheral Blood Mono-
nuclear Cell (PBMC) assays and Whole Blood (WB) assays.
The conventional PBMC assays require large volume of
blood samples when compared to WB assays. Thus, WB
assays gain importance in screening of large number of
antigens with the same blood sample; and paediatric
and field studies. So, we compared WB assay with
PBMC assay to know whether WB assays can be used as
an alternative or not.
In this study, we compared the lymphocyte proliferation
and IFN-γ levels in 1:5 and 1:10 diluted blood and PBMC
against MPT51 recombinant antigen of M. tuberculosis,




The study was approved by the Institutional Ethics com-
mittee of National Institute for Research in Tuberculosis
(NIRT) and written consent was obtained from the
volunteers before recruitment into the study. Eight
healthy laboratory volunteers were recruited in the present
study from NIRT (formerly Tuberculosis Research Centre),
Chennai, India. These individuals had no history of
tuberculosis on the basis of personal history; physical
examination, chest x-ray, and negative acid fast bacilli
sputum smear microscopy. All the study subjects were
TST positive. All participants aged from 25 to 45 years.
All subjects were HIV negative as determined by Tridot
(J.Mitra & co, India) and Retroquic (Qualprodiagnostics,
India) assays with serum.
Antigens and mitogens
M. tuberculosis PPD was obtained from Statens Serum
Institute, PHA was purchased from Sigma Chemical
Company, MO, USA and MPT51 recombinant protein
was cloned, over expressed and purified as described
previously [9].
Lymphocyte proliferation assay
Briefly, 10 ml of heparinized venous blood was drawn
from each study subject. For WB assay, 1:5 and 1:10
dilutions were made with sterile RPMI 1640 medium
(Sigma Chemical Company, MO, USA), supplemented
with penicillin (100 IU/ml), streptomycin (0.1 mg/ml),
L-glutamine (0.29 gm/l) and amphotericin B (5mg/ml) and
was seeded in 96-well flat bottom plates at 200 μl/well.
PBMC were isolated by Ficoll-Hypaque density cen-
trifugation. A total of 2x105cells/well were cultivated
in complete culture medium, supplemented with 10%
Human AB serum. Cultures were stimulated eitherwith MPT51 recombinant protein of M. tuberculosis
(5 μg/ml), or PHA (5 μg/ml) or PPD (5 μg/ml). Cells
cultured under similar conditions without any stimula-
tion served as the negative control. The cultures were
set up in triplicates and incubated for 6 days at 37°C in
5%CO2 atmosphere.
Sixteen hours before termination of cultures, 1 μCi of
tritiated (3H) thymidine (Board of Radiation and Isotope
Technology, MA, USA) was added to each well. The cells
were then harvested onto glass fiber filters on a cell har-
vester and allowed to dry overnight. 2ml of scintillation
fluid (0.05mg/ml POPOP and 4mg/ml PPO in lit. of tolu-
ene) was added to each tube containing the dried filter discs
and counted by using a liquid scintillation beta counter.
The proliferation was measured as uptake of tritiated
thymidine by cells and expressed as stimulation index
(SI) which was calculated as
Stimulation Index SIð Þ ¼ Mean counts per minute with antigen
Mean counts per minute without antigen
Interferon-γ measurement
For quantification of IFN-γ, in all 1:5 and 1:10 diluted
blood and PBMC cell-free culture supernatants from
lymphocyte proliferation assay were harvested after 6 days
of in vitro stimulation with or without antigen stimuli and
stored at −80°C until assayed. IFN-γ production was deter-
mined by standard ELISA technique using commercially
available BD opt-EIA Kit (BD Biosciences, Franklin Lakes,
NJ, USA) as per the manufacturer’s instructions.
Statistical analysis
Statistical analysis was performed by using GraphPad Prism
software version 5.0 (GraphPad software, CA, USA). One
way ANOVA was used for comparing lymphocyte prolifer-
ative responses and cytokine levels in all 1:5, 1:10 diluted
blood and PBMC assays against the antigens and mitogen.
Results
IFN-γ secretion in response to MPT51 recombinant
antigen of M. tuberculosis, PPD and PHA
T lymphocyte function was studied by measuring IFN-γ
levels in 1:5, 1:10 diluted WB and PBMCs stimulated with
the antigens and mitogen. One way ANOVA was used to
compare the differences among the three assay conditions.
The mean values of IFN-γ levels in 1:5, 1:10 diluted
WB and PBMC’s stimulated with MPT 51 recombinant
antigen were 55.71pg/ml, 166.3pg/ml and 54.86pg/ml
respectively. Though there was a difference in IFN-γ
secretion in all the three assay conditions, the difference
was not statistically significant (p = 0.39) (Figure 1).
In PPD stimulated 1:5, 1:10 diluted WB and PBMCs
cultures, the mean values of secreted IFN-γ levels were




















Figure 1 IFN-γ levels against MPT51 recombinant antigen of
M. tuberculosis. Based on the statistical analysis i.e., ONE way ANOVA,























Figure 3 Lymphocyte proliferation against MPT51 recombinant
antigen and PPD of M. tuberculosis. From statistical analysis i.e.,
ONE way ANOVA, differences between these assays against antigen
and PPD are not significant (p = 0.58 and 0.45 respectively).
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(p = 0.20) (Figure 2).
Whereas the IFN-γ levels in 1:5, 1:10 diluted WB and
PBMCs in response to PHA, showed statistically significant
difference (p = 0.017) (Figure 2). The mean values of
IFN-γ in 1:5, 1:10 diluted WB and PBMC cultures
stimulated by PHA were 3375pg/ml, 3513pg/ml and
2064pg/ml respectively.Lymphocyte proliferation response against MPT51
recombinant antigen of M. tuberculosis, PPD and PHA
Apart from IFN-γ measurement, T lymphocyte function
was also studied by its proliferative ability in 1:5, 1:10
diluted WB and PBMC’s stimulated with the antigens and
mitogen. The differences among the three assay conditions
were compared by using one way ANOVA.
Here, proliferative response of lymphocytes was mea-






















Figure 2 IFN-γ levels against PPD of M. tuberculosis and PHA.
ONE way ANOVA analysis shows that p = 0.20 and 0.0171 for PPD
and PHA respectively.In all the assay conditions i.e. in 1:5, 1:10 diluted WB and
PBMC, lymphocyte proliferation response against MPT
51 recombinant antigen of M. tuberculosis was similar
(Figure 3). On doing one way ANOVA for comparison,
there was no statistically significant difference (p = 0.58)
among the three conditions. Although, in all the three assay
conditions, high thymidine uptake values were observed in
response to PPD and PHA (represented positive controls),
the difference was not statistically significant (p = 0.45 &
0.60 respectively) (Figure 3 & Figure 4).
These results suggest that the IFN-γ secretion and
lymphocyte proliferation patterns were similar in 1:5 and
1:10 diluted WB and in PBMC assays against the anti-
gens and mitogen.
Discussion
This is a preliminary study, where we included only 8 study
subjects to know whether we can use 1:5 and 1:10 diluted
whole blood assays or not. Healthy laboratory volunteers





















Figure 4 Lymphocyte proliferation against PHA. ONE way
ANOVA shows p = 0.60. It indicates there is no statistical significance
difference between the assays.
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T cells, which upon re-stimulation with M. tuberculosis
specific antigens, will induce immune response and
secrete cytokines. Since M. tuberculosis is an intra cellular
pathogen, cell mediated immunity, especially T cells play a
crucial role in immune response. T cell function was
primarily measured by their proliferative capacity against
the crude and recombinant antigens as well as mitogen.
Apart from that, IFN-γ is a key cytokine involved in the
control of tuberculosis. So, cell proliferation and IFN-γ
were used as the parameters to optimize the assay from
long term culture condition (6 days). Long-term assays
have advantages over short term assays, because during
long term incubations, there will be an expansion of
antigen specific IFN-γ secreting central memory T- cells.
Therefore long-term assays are more sensitive to check
diagnostic and vaccine potential of M. tuberculosis specific
antigens [10].
As described by many authors [11], even though the
conventional PBMC assays are specific in T cell functional
analysis (since there is no influence of other whole blood
components such as neutrophils and plasma), it requires
large sample volume and there will be considerable cell
loss during isolation.
The alternative T cell assay, WB assay is advantageous
over PBMC assays; it requires small sample size, it is
rapid and there is no need for cell separation. But the
main disadvantage of this technique is that the number
of cells cultured is neither known nor controlled. As such,
variations in cytokine production between individuals, and
in different physiological and pathological states, could rep-
resent either changes in the numbers of cytokine producing
cells (e.g. T lymphocytes, monocytes) or an altered ability
of those cells to produce cytokines, or both. In contrast,
purified PBMC cultures include a precisely known number
of cytokine-producing cells.
Thus, this study indicates that, although there is
substantial inter-individual variation in ex vivo cytokine
production, the production of any given cytokine by a
particular individual is stable in the absence of changes in
health and lifestyle factors, and that whole blood cultures
can be used instead of purified PBMC cultures to measure
a variety of cytokines.
In addition to describing the variation in cytokine pro-
duction, the aim of this study was to identify whether
whole blood cultures could be used to measure cytokine
production rather than purified PBMCs. This might be
an advantage in field work and/or where large numbers
of blood samples need to be processed [12].
In this study, we employed two different whole blood
dilution conditions i.e. 1:5 and 1:10 dilutions for T cell
functional analysis in comparison to PBMC assays. For
PBMC cultures, 10% AB serum which has been added
provide nutrients that are equal to 1:10 diluted wholeblood concentration. Thus, in this study we used the
highest dilution factor i.e. 1:10.
Based on one way ANOVA results, we observed no sta-
tistically significant difference in lymphocyte proliferation
in 1:5, 1:10 diluted WB and PBMC assays against all the
three antigens and mitogen.
Whereas in the case of IFN-γ levels, there was no
statistically significant difference in all the assays
against recombinant protein and crude protein. But
there was a significant increase (p = 0.0379) in IFN-γ
levels in 1:10 diluted WB assay against mitogen, when
compared to PBMC assay.
When compared to 1:5 diluted WB and PBMCs,
stimulation index and IFN-γ levels were high in 1:10
diluted WB assays when stimulated with antigens and
mitogen. Based on these results we concluded that 1:10
diluted WB assays are more promising and work better
than both 1:5 diluted WB and PBMC assays.
In comparison with 1:5 diluted WB and PBMCs,
availability of nutrients during long term incubation
will be more in 1:10 diluted WB because of higher volume
of RPMI 1640 medium, which would have helped to avoid
cell crowding during the incubation. This might play an
essential role in optimal T-cell activation and secretion of
IFN-γ against the antigens and mitogen in 1:10 diluted
WB assays.
Conclusions
Based on these results we conclude that 1:10 diluted
WB assays can be used as an alternative immunological
assay. When compared to PBMC and 1:5 diluted WB
assays, 1:10 diluted WB assays require very small volume of
blood, so that these assays are useful in paediatric and field
studies. It is also useful in screening large number of
antigens in the same blood sample [13]. Thus 1:10 diluted
WB assays are more useful than PBMC assays.
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